Characteristic differences in radiation‐induced DNA damage response in human papillomavirus‐negative and human papillomavirus‐positive head and neck cancers with accumulation of fractional radiation dose. Issue 10 (8th July 2021)

• Record Type: Journal Article
• Authors: Reid, Paul; Staudacher, Alexander H.; Marcu, Loredana G.; Olver, Ian; Moghaddasi, Leyla; Brown, Michael P.; Bezak, Eva
• Is Part Of: Head & neck. Volume 43:Issue 10(2021)
• Page Start: 3086
• Page End: 3096
• Publication Date: 2021-07-08
• Subjects: γH2AX -- fractionated radiation therapy -- HNSCC -- HPV -- micronuclei; Head -- Diseases -- Periodicals; Neck -- Diseases -- Periodicals; Head -- Periodicals; Neck -- Periodicals; Face -- Periodicals; 617.51059
• DOI: 10.1002/hed.26802
• Languages: English
• ISSNs: 1043-3074

Abstract

Abstract: Background: Superior treatment responses by patients with human papillomavirus (HPV) positive head and neck squamous cell carcinoma (HNSCC), compared to patients with HNSCC from other causes, drive biomarker research to optimize treatment. Most HNSCC patients receive radiation therapy delivered as a fractionated course. Changing HPV status in HNSCC from a positive prognostic marker to a predictive one requires biomarkers that capture cellular radiation response to cumulative dose. Methods: Nuclear enlargement, γH2AX expression and micronuclei count, were studied in six HNSCC cell lines after 4 Gy fractionated X‐irradiation. Results: All HNSCC cell lines displayed altered cellular responses, indicating increasing inability to repair radiation damage with subsequent radiation fractions. Increases in nuclear area were significantly greater among HPV positive cell lines (207% and 67% for the HPV positive and HPV negative groups, respectively). Conclusions: A different character of DNA repair dysfunction in the HPV positive group suggests greater chromosomal translocation with accumulated radiation dose.